Novel Molecular Targets and Innovative Therapeutic Perspective in Medulloblastoma | MicrobiomeTrials← Back to trialsNCT06959979
Novel Molecular Targets and Innovative Therapeutic Perspective in Medulloblastoma
RecruitingEARLY_PHASE1INTERVENTIONAL
Trial Details
Start: 2024-11-25Est. Completion: 2026-08-31
Enrollment target: 60 participants Locations- Fondazione Policlinico Gemelli Irccs, Roma, ROMA, Italy
Other microbiome trials you might be interested in
Neoplasms, BrainGlioblastoma MultiformeGlioblastoma of CerebellumNeoplasmsAstrocytomaAstrocytoma, CerebellarNeuroectodermal TumorsNeuroectodermal Tumors, PrimitiveCerebellar PNET, ChildhoodCerebellar NeoplasmsCerebellar Neoplasms, PrimaryCerebellar Neoplasm, MalignantCerebellar Neoplasm Malignant PrimaryNeoplasm MetastasesNeoplasm MalignantNeoplasms, NeuroepithelialNeoplasms, Germ Cell and Embryonal
Neoplasms by Histologic Type
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Central Nervous System Neoplasms, Primary
Central Nervous System Neoplasms, Malignant
Nervous System Neoplasms
Neoplasms by Site
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Medulloblastoma Recurrent
HSV
Virus
Pediatric Brain Tumor
Nervous System Cancer
Primitive Neuroectodermal Tumor (PNET) of Cerebellum
This study is a clinical trial to determine the safety of inoculating G207 (an experimental virus therapy) into a recurr…
Birmingham, United StatesEst. completion Sep 1, 2026
Central Nervous System NeoplasmsBrain TumorBrain Tumor, RecurrentBrain Tumor, PediatricBrain Tumor AdultMedulloblastomaMedulloblastoma, ChildhoodMedulloblastoma, AdultMedulloblastoma RecurrentEpendymomaAtypical Teratoid/Rhabdoid TumorEmbryonal Tumor With Multilayered RosettesPineoblastomaLeptomeningeal Disease
The purpose of this research study is to test the safety and effectiveness of a cell therapy at different doses for chil…
Boston, United StatesEst. completion Aug 31, 2030